Emerson Elec Co Stock Price, News & Analysis

Emerson (NYSE: EMR) was selected by South32 to provide advanced automation solutions for the Hermosa mine project in Arizona, a multi-million-dollar program to deploy integrated remote operations systems for South32’s first “next generation mine.”

Emerson will supply its DeltaV automation platform, centralized control software, asset management systems, smart field devices and remote-operations technologies to support South32’s remote operations center, Centro, which will be located about 30 miles from the mine and host approximately 200 full-time staff. The deployment aims to improve safety, efficiency and environmental performance while enabling lower-emission mining and critical-minerals production.

Emerson (NYSE: EMR) was selected by Lithium Americas to supply comprehensive automation and technical services for the Thacker Pass lithium project in northern Nevada.

Emerson’s scope covers field instrumentation, process control hardware and software, final control valves, reliability technologies and local maintenance support via partner Caltrol. Thacker Pass Phase 1 is expected to produce up to 40,000 tonnes of battery-quality lithium carbonate per year, enough for batteries for up to 800,000 electric vehicles. Construction is underway and Emerson says its automation aims to improve safety, uptime, capital efficiency and total cost of ownership.

Emerson (NYSE: EMR) reported fiscal Q4 and full-year 2025 results for the period ended Sept. 30, 2025, and provided initial 2026 guidance. Q4 net sales were $4,855 million, up 5% year-over-year; FY sales were $18,016 million, up 3% year-over-year. GAAP EPS was $1.12 in Q4 and $4.03 for FY 2025; Adjusted EPS was $1.62 in Q4 and $6.00 for FY 2025. Emerson reported margin expansion (FY adjusted segment EBITA margin to 27.6%) and FY free cash flow of $3,245 million.

The board approved a 5% quarterly dividend increase to $0.555 per share (payable Dec. 10, record Nov. 14) and authorized repurchases of up to 50 million shares, in addition to ~20 million shares remaining from a prior authorization. 2026 guidance: Adjusted EPS $6.35–$6.55, GAAP EPS $4.73–$4.93, operating cash flow $4.0–$4.1B, free cash flow $3.5–$3.6B, and planned cash returns of ~$2.2B (~$1.0B repurchases, ~$1.2B dividends).

Emerson (NYSE: EMR) will report its fourth quarter and full year 2025 results before market open on Wednesday, November 5, 2025. Senior management will host an investor conference call the same day at 8:30 a.m. ET / 7:30 a.m. CT.

Investors can listen live and view presentation slides after completing a brief registration on Emerson's Investors website at https://ir.emerson.com. A replay will be available on the same site for three months following the webcast.

Emerson (NYSE: EMR) has launched Guardian Virtual Advisor, an AI-powered software solution designed to enhance industrial automation system performance. The solution leverages artificial intelligence and Emerson's extensive domain expertise to provide rapid, self-service advice for system maintenance and troubleshooting.

Built upon Emerson's Guardian Digital Platform's two decades of accumulated knowledge, the Virtual Advisor enables natural language queries and delivers instant answers with relevant documentation. Initially available for DeltaV distributed control systems, the platform will expand to include AMS and Ovation platforms. This innovation addresses a critical market need, considering Frost & Sullivan's estimate of over $1 trillion in global industrial operational losses.

Emerson (NYSE: EMR) announced that its President and CEO Lal Karsanbhai and CFO Mike Baughman will present at the J.P. Morgan U.S. All Stars Conference in London, England. The presentation is scheduled for September 16th, 2025 at 2:00 p.m. BST (8:00 a.m. Central Time). Investors can access the audio webcast through Emerson's investor relations website, where it will also be archived for future reference.

Emerson (NYSE:EMR) has become the largest corporate sponsor of 'How Are We Today?', a new mental health educational TV program premiering September 15 on Public Television. The show, created by Tyler Coe, who has personal experience with bipolar disorder, features seven episodes covering various mental health conditions including depression, social anxiety, ADHD, and panic attacks.

The Austin-based program will be available weekly on the PBS app and local PBS affiliates, with Austin PBS serving as the presenting station. The show aims to provide free education and practical therapeutic techniques for viewers aged 12 and up, featuring host Tyler Coe alongside a diverse cast and resident psychologist Dr. Erin Newins.

Emerson (NYSE: EMR) reported strong Q3 2025 results with net sales reaching $4.553 billion, up 4% from the previous year. The company achieved notable improvements in profitability, with pretax earnings margin expanding 570 basis points to 16.1% and GAAP earnings per share increasing 72% to $1.03.

The company updated its fiscal 2025 outlook, projecting net and underlying sales growth of ~3.5%. Adjusted EPS guidance was raised to ~$6.00, with operating cash flow expected to reach ~$3.6B. Emerson plans to return ~$2.3B to shareholders through $1.1B in share repurchases and ~$1.2B in dividends. The company also declared a quarterly dividend of $0.5275 per share, payable September 10, 2025.

Emerson (NYSE: EMR) has announced the integration of Nigel AI Advisor into its flagship test software products, marking its first step in incorporating AI technology into its test and measurement portfolio. The AI advisor, built on advanced language models, is now enabled in NI LabVIEW and NI TestStand software.

Nigel AI Advisor helps engineers improve productivity by analyzing code, providing improvement recommendations, and offering plain language assistance for hundreds of functions through a secure cloud platform. The technology aims to reduce test complexity and is part of Emerson's broader strategy to integrate AI capabilities across its NI test and measurement software suite.